E
Jack Nathan Medical Corp. JNH.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 12/20/2024Downgrade
Jack Nathan Medical Corp. (JNH.V) was downgraded to E+ from D- on 12/20/2024 due to a decline in the volatility index.
D
Sell 12/2/2024Upgraded
Jack Nathan Medical Corp. (JNH.V) was upgraded to D- from E+ on 12/2/2024 due to an increase in the valuation index, volatility index and total return index.
E
Sell 3/14/2023Downgrade
Jack Nathan Medical Corp. (JNH.V) was downgraded to E+ from D on 3/14/2023 due to a decline in the valuation index.
D
Sell 2/9/2023Upgraded
Jack Nathan Medical Corp. (JNH.V) was upgraded to D from E+ on 02/09/2023.
E
Sell 2/8/2023Downgrade
Jack Nathan Medical Corp. (JNH.V) was downgraded to E+ from D on 02/08/2023.
D
Sell 12/23/2022Upgraded
Jack Nathan Medical Corp. (JNH.V) was upgraded to D from D- on 12/23/2022 due to a significant increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0155 to -$0.0075, EBIT increased 35.45% from -$937.3 to -$605, and operating cash flow increased 28.55% from -$142.9 to -$102.1.
D
Sell 10/21/2022Downgrade
Jack Nathan Medical Corp. (JNH.V) was downgraded to D- from D on 10/21/2022 due to a decline in the volatility index.
D
Sell 10/6/2022Upgraded
Jack Nathan Medical Corp. (JNH.V) was upgraded to D from D- on 10/6/2022 due to an increase in the growth index and volatility index. Earnings per share increased from -$0.0158 to -$0.0155.
D
Sell 8/1/2022Downgrade
Jack Nathan Medical Corp. (JNH.V) was downgraded to D- from D on 8/1/2022 due to a decline in the volatility index.
D
Sell 7/15/2022Upgraded
Jack Nathan Medical Corp. (JNH.V) was upgraded to D from D- on 7/15/2022 due to an increase in the valuation index.
D
Sell 6/30/2022Downgrade
Jack Nathan Medical Corp. (JNH.V) was downgraded to D- from D on 6/30/2022 due to a decline in the solvency index and valuation index. The quick ratio declined from 0.72 to 0.53.
D
Sell 6/23/2022Upgraded
Jack Nathan Medical Corp. (JNH.V) was upgraded to D from D- on 6/23/2022 due to an increase in the volatility index and valuation index.
D
Sell 6/3/2022Downgrade
Jack Nathan Medical Corp. (JNH.V) was downgraded to D- from D on 6/3/2022 due to a decline in the solvency index, volatility index and valuation index. The quick ratio declined from 1.46 to 0.72, and debt to equity increased from 0.1 to 0.15.
D
Sell 5/18/2022Upgraded
Jack Nathan Medical Corp. (JNH.V) was upgraded to D from E+ on 5/18/2022 due to an increase in the volatility index and valuation index.
E
Sell 5/13/2022Downgrade
Jack Nathan Medical Corp. (JNH.V) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index.
D
Sell 5/11/2022Upgraded
Jack Nathan Medical Corp. (JNH.V) was upgraded to D from E+ on 5/11/2022 due to an increase in the volatility index and total return index.
E
Sell 5/1/2022Downgrade
Jack Nathan Medical Corp. (JNH.V) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
D
Sell 4/21/2022Upgraded
Jack Nathan Medical Corp. (JNH.V) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index.
E
Sell 4/20/2022Downgrade
Jack Nathan Medical Corp. (JNH.V) was downgraded to E+ from D- on 04/20/2022.
D
Sell 3/31/2022Downgrade
Jack Nathan Medical Corp. (JNH.V) was downgraded to D- from D on 3/31/2022 due to a decline in the volatility index and total return index.
D
Sell 3/15/2022Upgraded
Jack Nathan Medical Corp. (JNH.V) was upgraded to D from D- on 3/15/2022 due to an increase in the volatility index and total return index.
D
Sell 2/17/2022Downgrade
Jack Nathan Medical Corp. (JNH.V) was downgraded to D- from D on 2/17/2022 due to a decline in the volatility index.
D
Sell 2/2/2022Upgraded
Jack Nathan Medical Corp. (JNH.V) was upgraded to D from D- on 2/2/2022 due to an increase in the volatility index.
D
Sell 1/18/2022Downgrade
Jack Nathan Medical Corp. (JNH.V) was downgraded to D- from D on 1/18/2022 due to a decline in the volatility index and total return index.
D
Sell 1/3/2022Upgraded
Jack Nathan Medical Corp. (JNH.V) was upgraded to D from D- on 1/3/2022 due to a noticeable increase in the growth index and total return index. Total revenue increased 21.75% from $1.58M to $1.92M.
D
Sell 11/23/2021Upgraded
Jack Nathan Medical Corp. (JNH.V) was upgraded to D- from E+ on 11/23/2021 due to an increase in the volatility index and valuation index.
E
Sell 11/8/2021Downgrade
Jack Nathan Medical Corp. (JNH.V) was downgraded to E+ from D- on 11/8/2021 due to a major decline in the total return index, growth index and volatility index. Operating cash flow declined 52.03% from -$648.1 to -$985.3, EBIT declined 26.88% from -$1.1M to -$1.4M, and earnings per share declined from -$0.0159 to -$0.0175.
D
Sell 7/1/2021Upgraded
Jack Nathan Medical Corp. (JNH.V) was upgraded to D- from E on 7/1/2021 due to a major increase in the growth index and solvency index. Total revenue increased 80.73% from $556.7 to $1.01M, earnings per share increased from -$0.0277 to -$0.0159, and EBIT increased 22.03% from -$1.41M to -$1.1M.
E
Sell 4/1/2021Upgraded
Jack Nathan Medical Corp. (JNH.V) was upgraded to E from E- on 4/1/2021 due to a significant increase in the solvency index and total return index. The quick ratio increased from 0.49 to 15.95.
E
Sell 12/29/2020None
Jack Nathan Medical Corp. (JNH.V) was downgraded to E- from U on 12/29/2020.
Weiss Ratings